MGAT5 and central nervous system cancer: It has been shown that increased expression of MGAT5, which mediates N-glycosylation of receptor protein tyrosine phosphatase type μ (RPTPμ) with β1,6-GlcNAc-branched N-glycans, reduces its activity, thereby increasing the invasiveness of glioma cells [33].